author-photo

Bahram Forouzesh

University of Texas Health Science Center at San Antonio

13

Papers

612

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Phase I and Pharmacokinetic Study of Sequential Paclitaxel and Trabectedin Every 2 Weeks in Patients with Advanced Solid Tumors

2010 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (20)
Phase I and Pharmacokinetic Study of Trabectedin as a 1- or 3-hour Infusion Weekly in Patients with Advanced Solid Malignancies

2009 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (25)
Erratum: A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes (Investigational New Drugs DOI: 10.1007/s10637-006-9031-6)

2007 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (1)
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas

2007 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (42)
Phase I and Pharmacokinetic Study of Pemetrexed with High-Dose Folic Acid Supplementation or Multivitamin Supplementation in Patients with Locally Advanced or Metastatic Cancer

2007 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (46)
140 A two-stage phase II study of the matrix metalloproteinase inhibitor (MMPI) Col-3 in patients with advanced soft tissue sarcoma (ASTS) — report of stage I data

2004 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

2003 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (114)
A P hase I a nd P harmacokinetic S tudy o f P egylated Camptothecin a s a 1 -Hour I nfusion E very 3 W eeks i n P atients With A dvanced S olid M alignancies

2003
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies

2003 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (14)